Respiratory muscle exercise with Power Breathe® and Respiron® in healthy people
Phase 1
Recruiting
- Conditions
- Muscle Strength DynamometerE07.230.460
- Registration Number
- RBR-6nrt3x
- Lead Sponsor
- Pontifícia Universidade Católica de Goiás
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Age between 18 and 59 years, who present normal spirometry.
Exclusion Criteria
Individuals with cardiac disease; pulmonary; neurological or cognitive; smoking; retinal detachment; glaucoma; recent ophthalmic surgeries as well as corticosteroids; bronchodilators and ergogenic supplements; will be excluded from regular physical activity for less than three months.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected to increase inspiratory muscle strength in G1 and G2, with no significant difference in the MIP delta (difference between pre and post intervention). G2 will not increase PImax, or it will increase less than 10 cmH2O. The increase in PImax will be considered significant through statistical tests (means comparison tests). In the delta (pre and post intervention difference) a value of 10 cmH2O will be considered a clinically significant minimum difference.
- Secondary Outcome Measures
Name Time Method It is expected not to find significant changes<br>spirometric data. CV will increase only in the Respiron group (G1), verified by means of statistical tests (Means comparison tests).